MBX-8025: Phase II data

A double-blind, international Phase II trial in 26 evaluable PBC patients who had an inadequate response to ursodiol and who completed >=2 weeks of

Read the full 249 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE